Sample Article - Use of Domperidone as a Prokinetic and Antiemetic

Sample Articles from IJPC

About IJPC

The International Journal of Pharmaceutical Compounding (IJPC) is a bi-monthly scientific and professional journal emphasizing quality pharmaceutical compounding.

The Journal is available in both printed and electronic format with digital versions of individual articles and complete issues delivered in Adobe® Acrobat PDF format.

Search the Journal by issue, topic or keyword.

Request a free copy of the Journal

Request a copy of
"Use of Domperidone as a Prokinetic and Antiemetic"

Read Abstract

A link to this sample article download page may be freely posted on web sites, chat rooms, and message boards provided that attribution to IJPC is included. The URL for this item is http://ijpc.com/Sample/Article.cfm?SID=85

The sample document may NOT be electronically posted, published, or redistributed without the prior permission of IJPC.

Complete the following to have a download link emailed to you.

Name:
Email:
Organization:
Used For:

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Mar/Apr 2005 Pg. 120-125 View Sample	Use of Domperidone as a Prokinetic and Antiemetic Author(s): Albright Lisa M
Jul/Aug 2019 Pg. 316	Domperidone 5 mg/mL in Oral Mix Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 276-286	Compounding Prokinetic Medications for Companion Animals Author(s): Gaskins Jessica
Nov/Dec 2021 Pg. 500	Domperidone 5 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 250-251	Nausea and Vomiting in Hospice Patients Author(s): Boomsma Diane
May/Jun 2014 Pg. 203-207	Literature Review: The Dual Role of Domperidone in Gastroparesis and Lactation Author(s): Phan Ha, DeReese Annie, Day A J, Carvalho Maria
Jan/Feb 2006 Pg. 61	Domperidone 1-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Mar/Apr 2006 Pg. 95-98	ABHR Gel in the Treatment of Nausea and Vomiting in the Hospice Patient Author(s): Moon Richard B
Mar/Apr 2013 Pg. 113-123	Nausea and Vomiting in Pregnancy: A Review of the Pathology and Compounding Opportunities Author(s): Zur Eyal
Jan/Feb 1997 Pg. 28	Antiemetic Suppositories of the Gralla Type Author(s): Allen Loyd V Jr
May/Jun 1997 Pg. 175	Antiemetic Injection for Cancer Chemotherapy Author(s): Allen Loyd V Jr
Sep/Oct 1997 Pg. 328	Metoclopramide-Lorazepam-Mannitol-Prochlorperazine Antiemetic Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 243	Metoclopramide 5-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2016 Pg. 426-434	Stability of Allopurinol, Amitriptyline Hydrochloride, Carbamazepine, Domperidone, Isoniazid, Ketoconazole, Lisinopril, Naproxen, Paracetamol (Acetaminophen), and Sertraline Hydrochloride in SyrSpend SF PH4 Oral Suspensions Author(s): Polonini Hudson C, Loures Sharlene, de Araujo Edson Peter, Brandão Marcos Antônio F, Ferreira Anderson O
Sep/Oct 2004 Pg. 329-335	Domperidone in Lactation: Use as a Galactagogue Author(s): Albright Lisa M
Sep/Oct 2004 Pg. 332	Domperidone Capsules 10-, 20- and 30-mg Author(s): Albright Lisa M
May/Jun 2009 Pg. 220-221	Promethazine 25 mg/mL in Pluronic Lecithin Organogel for Nausea and Vomiting in a Pediatric Patient: A Case Report Author(s): Muller George
Jul/Aug 2011 Pg. 308-315	Transdermals: The Skin as Part of a Drug Delivery System Author(s): Allen Loyd V Jr
Sep/Oct 2011 Pg. 419	Granisetron Hydrochloride 0.2-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
Jul/Aug 2008 Pg. 372-374	Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Jul/Aug 2008 Pg. 368-371	Physical and Chemical Stability of Palonosetron Hydrochloride with Glycopyrrolate and Neostigmine During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
Sep/Oct 2008 Pg. 460-462	Compatibility and Stability of Palonosetron Hydrochloride with Lactated Ringer's, Hetastarch in Lactated Electrolyte, and Mannitol Injections During Simulated Y-Site Administration Author(s): Ben Michel, Kupiec Thomas C, Trusley Craig, Trissel Lawrence A
May/Jun 2006 Pg. 222	Granisetron 0.05-mg/mL Oral Suspension Author(s): Allen Loyd V Jr
May/Jun 2006 Pg. 234-236	Physical and Chemical Stability of Palonosetron Hydrochloride with Dacarbazine and with Methylprednisolone Sodium Succinate During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A, Zhang Yanping
Nov/Dec 2007 Pg. 520-524	Palonosetron Hydrochloride Compatibility and Stability with Three Beta-Lactam Antibiotics During Simulated Y-Site Administration Author(s): Ben Michel, Trusley Craig, Kupiec Thomas C, Trissel Lawrence A
May/Jun 2005 Pg. 235-237	Physical and Chemical Stability of Palonosetron Hydrochloride with Lorazepam and Midazolam Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 238-241	Physical and Chemical Stability of Palonosetron Hydrochloride with Topotecan Hydrochloride and Irinotecan Hydrochloride during Simulated Y-Site Administration Author(s): Trissel Lawrence A, Xu Quanyun A
May/Jun 2005 Pg. 242-246	Bioavailability of Promethazine in a Topical Pluronic Lecithin Organogel: A Pilot Study Author(s): Glisson James K, Wood Rebecca L, Kyle Patrick B, Cleary John D
Nov/Dec 2005 Pg. 475	Dolasetron 10-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jan/Feb 2017 Pg. 66-75	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Dexamethasone Sodium Phosphate Author(s): Wu George, Yeung Stanley, Chen Frank
Jan/Feb 2017 Pg. 76-82	Compatibility and Stability of Rolapitant Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Author(s): Wu George, Yeung Stanley, Chen Frank
Nov/Dec 2017 Pg. 495	Promethazine Hydrochloride 12.5 mg/0.1 mL in PLO Gel Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 76-85	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Palonosetron Hydrochloride Injection and Dexamethasone Sodium Phosphate Injection Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank
Jan/Feb 2018 Pg. 86-94	Compatibility and Stability of VARUBI (Rolapitant) Injectable Emulsion Admixed with Intravenous Granisetron Hydrochloride Author(s): Wu George, Powers Dan, Yeung Stanley, Chen Frank, Neelon Kelly
Mar/Apr 2018 Pg. 150	Prochlorperazine Edisylate 0.5% Nasal Spray Author(s): Allen Loyd V Jr
May/Jun 2018 Pg. 237	Rolapitant Injectable Emulsion with Dexamethasone Sodium Phosphate Admixture Author(s): Allen Loyd V Jr
May/Jun 2020 Pg. 225	Dexamethasone 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 246	Prochlorperazine 5-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 163	Promethazine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 339	Ondansetron Hydrochloride 2-mg/mL Injection Author(s): Allen Loyd V Jr
Jan/Feb 2013 Pg. 66	Granisetron 1-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2013 Pg. 247-253	Effect of Formulation pH on Transdermal Penetration of Antiemetics Formulated in Poloxamer Lecithin Organogel Author(s): Woodall Rachel, Arnold John J, McKay Doug, Abill C Scott
Jan/Feb 2014 Pg. 62	Droperidol 2.5-mg/mL Injection Author(s): Allen Loyd V Jr
Nov/Dec 2014 Pg. 520-525	High-Performance Liquid Chromatographic Method Optimization for Ondansetron Assay in Extemporaneous Topical Gel and in Marketed Products Author(s): Quamrun Masuda, Mamoon Rashid, Nasheed Shams, Mullins Randy
May/Jun 2015 Pg. 247	Scopolamine Hydrobromide -.4-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2015 Pg. 344-347	Stability of Diphenhydramine Hydrochloride, Lorazepam, and Dexamethasone Sodium Phosphate in 0.9% Sodium Chloride Stored in Polypropylene Syringes Author(s): Anderson Collin R, Halford Zachery, MacKay Mark
Nov/Dec 2015 Pg. 507	Chlorpromazine Hydrochloride 25-mg/mL Injection, Preserved Author(s): Allen Loyd V Jr
Jan/Feb 2016 Pg. 48	Aprepitant 80-mg Capsules Author(s): Allen Loyd V Jr
Jul/Aug 2016 Pg. 318	Dolasetron Mesylate 20-mg/mL Injection Author(s): Allen Loyd V Jr
Sep/Oct 2020 Pg. 406	Ketamine 60.6-mg/mL, Acepromazine 0.6-mg/mL, and Xylazine 6.67-mg/mL Injection (Vet-Rat and Hamster); Ketamine 6.06-mg/mL, Acepromazine 0.06-mg/mL, and Xylazine 0.667-mg/mL Injection (Vet-Mouse) Author(s): Allen Loyd V Jr
Nov/Dec 2022 Pg. 513	Granisetron Hydrochloride 005 mg/mL in Ora-Sweet and Ora-Plus Author(s): Allen Loyd V Jr
May/Jun 2023 Pg. 237	Migraine Headache Suppositories Author(s): Allen Loyd V Jr
Sep/Oct 2021 Pg. 358-362	Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA Author(s): Cabaleiro Joe
Jan/Feb 2005 Pg. 72-74	Chemical Stability of Metoclopramide Hydrochloride Injection Diluted with 0.9% Sodium Chloride Injection in Polypropylene Syringes at Room Temperature Author(s): Gupta Vishnu D
Nov/Dec 2005 Pg. 484-486	Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Author(s): Gupta Vishnu D
Mar/Apr 2006 Pg. 147-153	Initial Selection of Antiemetics in End-of-Life Care: A Retrospective Analysis Author(s): Tolen Laura, McMath Jill A, Alt Calvin, Weschules Douglas J, Knowlton Calvin H, McPherson Mary Lynn
Mar/Apr 2006 Pg. 89-93	Hospice from a Compounding Pharmacist's Perspective Author(s): Jones Marty
Nov/Dec 2004 Pg. 469	BAD (Benadryl, Ativan, and Decadron) Intravenous Drip Author(s): Allen Loyd V Jr
Jul/Aug 2000 Pg. 255-256	Custom-Making Medications for the Hospice Patient Author(s): Horwitz Robert
Mar/Apr 1998 Pg. 116-117	The Symptom Relief Kit for Hospice Patients Author(s): Petrin Ronald L
May/Jun 2003 Pg. 217	Dimenhydrinate 5-mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2003 Pg. 297	Chlorpromazine HCl 30-mg/mL Oral Concentrate Author(s): Allen Loyd V Jr
Mar/Apr 2008 Pg. 156-160	Compatibility and Stability of Palonosetron Hydrochloride with Four Neuromuscular Blocking Agents During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A
Mar/Apr 2008 Pg. 170-173	Compatibility and Stability of Palonosetron Hydrochloride with Gentamicin, Metronidazole, or Vancomycin During Simulated Y-Site Administration Author(s): Kupiec Thomas C, Ben Michel, Trusley Craig, Trissel Lawrence A
May/Jun 2008 Pg. 267	Promethazine Hydrochloride 2.5-mg/mL Rectal Solution Author(s): Allen Loyd V Jr
May/Jun 2008 Pg. 270-273	Evaluation of the Percutaneous Absorption of Promethazine Hydrochloride, In Vitro, Using the Human Ex Vivo Skin Model Author(s): Bassani August S, Banov Daniel, Lehman Paul A
Jul/Aug 2006 Pg. 288-290	Hospice Symptom Relief Kit: An Update Author(s): Petrin Ronald L
Jan/Feb 2009 Pg. 78-80	Compatibility and Stability of Palonosetron Hydrochloride and Propofol During Simulated Y-Site Administration Author(s): Trissel Lawrence A, Trusley Craig, Kupiec Thomas C, Ben Michel
Nov/Dec 2011 Pg. 504	Morphine 6-mg/mL, Haloperidol 0.5-mg/mL, and Hyoscine 6-mg/mL Infusion Author(s): Allen Loyd V Jr
Mar/Apr 2011 Pg. 170-173	Stability of Droperidol 0.625 mg/mL Diluted with 0.9% Sodium Chloride Injection and Stored in Polypropylene Syringes Author(s): McCluskey Susan V, Lovely Jenna K
May/Jun 2014 Pg. 190-200	Compounded Drugs of Value in Outpatient Hospice and Palliative Care Practice Author(s): McNulty John P, Muller George
Sep/Oct 2013 Pg. 418	Hydroxyzine Hydrochloride 25-mg/mL Injection Author(s): Allen Loyd V Jr
Jul/Aug 2012 Pg. 334	Diphenhydramine Hydrochloride 50-mg/mL Injection Author(s): Allen Loyd V Jr
Mar/Apr 2012 Pg. 161	Lorazepam 4-mg/mL Injection Author(s): Allen Loyd V Jr
May/Jun 2012 Pg. 182-188	A Concise Discussion of Headache Types, Part 2: Migraine Author(s): Williams LaVonn A
Jul/Aug 2020 Pg. 319	Lorazepam 1 mg/mL in a Nonaqueous Cosolvent Vehicle Author(s): Allen Loyd V Jr
Mar/Apr 2007 Pg. 158	Ondansetron Hydrochloride 0.8mg/mL Oral Liquid Author(s): Allen Loyd V Jr
Jul/Aug 2019 Pg. 317	Lorazepam 1 mg/mL in Anhydrous Organic Solvent System Author(s): Allen Loyd V Jr
Jan/Feb 2020 Pg. 60	Ondansetron Hydrochloride 0.8 mg/mL in SyrSpend SF pH4 Oral Suspension Author(s): Allen Loyd V Jr
Mar/Apr 2020 Pg. 168-175	Percutaneous Absorption of Lorazepam, Diphenhydramine Hydrochloride, and Haloperidol from ABH Gel Author(s): Dahal Amit, Neupane Rabin, Boddu Sai HS, Renukuntla Jwala, Khupse Rahul, Dudley Richard
Mar/Apr 2018 Pg. 151	Rolapitant Injectable Emulsion with Palonosetron Hydrochloride Admixture Author(s): Allen Loyd V Jr
Jan/Feb 2018 Pg. 30-39	Basics of Compounding: Providing Pharmacy Services to Bariatric Surgery Patients Author(s): McElhiney Linda F
Jul/Aug 2021 Pg. 322	BHR in PLO Gel (Benadryl, Haldol, and Reglan in Pluronic Lecithin Organogel) Author(s): Allen Loyd V Jr
Mar/Apr 2022 Pg. 143	Lorazepam 1 mg/mL in SyrSpend SF pH4 Author(s): Allen Loyd V Jr
May/Jun 2022 Pg. 236	Cinnarizine 1 mg/mL in Oral Medium-Chain Triglycerides Anhydrous Vehicle Author(s): Allen Loyd V Jr
Jan/Feb 2007 Pg. 82-85	Physical and Chemical Stability of Palonosetron with Metoclopramide and Promethazine During Simulated Y-Site Administration Author(s): Trusley Craig, Ben Michel, Kupiec Thomas C, Trissel Lawrence A

Related Articles